Medicamen Biotech Limited has entered into a Manufacturing & Supply Agreement with a leading Pharma distributor and marketing Company in US & Europe.
The manufacturing facility of the MBL's USFDA approved Oncology Unit shall be utilized to manufacture the product where it can make use of its manufacturing and process R & D strengths to provide value added custom manufacturing services for various entities.
Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 498.35 as compared to the previous close of Rs. 466.35. The total number of shares traded during the day was 1758 in over 412 trades.
The stock hit an intraday high of Rs. 501.15 and intraday low of 465.20. The net turnover during the day was Rs. 857167.00.